The Committee is responsible for preparing the European Medicines Agency’s (EMA) opinions on all questions concerning medicinal products for human use, in accordance with Regulation (EC) No 726/2004.
Hosted on MSN1mon
GSK Gets CHMP Nod for Expanded Use of HIV Combo & JemperliGSK plc’s GSK HIV subsidiary, ViiV Healthcare announced that the Europe Medicines Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) has rendered a positive ...
GlobalData on MSN4mon
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPAThe European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving ...
The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
Merck MRK announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate vaccine ...
Johnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) rendered a positive opinion for the expanded use of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback